There are no directors' trades from BetaShares NASDAQ 100 ETF (NDQ). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities. What is the ...
Steris (STE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug By Investing.com - Feb 07, 2025 SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback